These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30092098)

  • 1. Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.
    Nayak S; Bhatt MLB; Goel MM; Gupta S; Mahdi AA; Mishra A; Mehrotra D
    PLoS One; 2018; 13(8):e0202432. PubMed ID: 30092098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
    Keek S; Sanduleanu S; Wesseling F; Reinout de Roest ; Michiel van den Brekel ; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
    PLoS One; 2020; 15(7):e0237048. PubMed ID: 32722718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma.
    PLOS ONE Staff
    PLoS One; 2018; 13(8):e0203174. PubMed ID: 30138452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis.
    She Y; Nong X; Zhang M; Wang M
    PLoS One; 2019; 14(6):e0217659. PubMed ID: 31220104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: May the change of platelet to lymphocyte ratio be a prognostic factor for T3-T4 laryngeal squamous cell carcinoma: A retrospective study.
    Zhong B; Gu DY; Du JT; Chen F; Liu YF; Liu SX
    PLoS One; 2019; 14(12):e0226383. PubMed ID: 31805159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Quantitative Expression and Co-Localization of Wnt Signalling Related Proteins in Feline Squamous Cell Carcinoma.
    PLOS ONE Staff
    PLoS One; 2016; 11(9):e0163838. PubMed ID: 27656881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model.
    PLOS ONE Staff
    PLoS One; 2024; 19(7):e0307334. PubMed ID: 38990931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
    Owusu-Afriyie O; Owiredu WKBA; Owusu-Danquah K; Komarck C; Foltin SK; Larsen-Reindorf R; Acheampong E; Quayson SE; Prince ME; McHugh JB; Donkor P; Merajver SD; Brenner JC
    PLoS One; 2018; 13(12):e0209696. PubMed ID: 30566529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
    Pan Y; Zhou F; Zhang R; Claret FX
    PLoS One; 2020; 15(8):e0237943. PubMed ID: 32790751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
    Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
    Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma.
    Gaykalova DA; Mambo E; Choudhary A; Houghton J; Buddavarapu K; Sanford T; Darden W; Adai A; Hadd A; Latham G; Danilova LV; Bishop J; Li RJ; Westra WH; Hennessey P; Koch WM; Ochs MF; Califano JA; Sun W
    PLoS One; 2020; 15(5):e0233409. PubMed ID: 32401780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.
    Jiang Y; Zhang C; Shen W; Li Y; Wang Y; Han J; Liu T; Jia L; Gao F; Liu X; Chen M; Yi G; Dai H; He J
    PLoS One; 2024; 19(4):e0302499. PubMed ID: 38640103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort.
    Han M; Lee JP; Park S; Kim Y; Kim YC; Ahn C; Han DJ; Ha J; Jung IM; Lim CS; Kim YS; Kim YH; Oh YK
    PLoS One; 2017; 12(6):e0179779. PubMed ID: 28604822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes.
    Garcia MM; Gottschalk AR; Brajtbord J; Konety BR; Meng MV; Roach M; Carroll PR
    PLoS One; 2016; 11(10):e0164558. PubMed ID: 27711167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma.
    PLOS ONE Staff
    PLoS One; 2019; 14(6):e0218987. PubMed ID: 31220179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis.
    Shi D; Wu F; Gao F; Qing X; Shao Z
    PLoS One; 2017; 12(10):e0186670. PubMed ID: 29023583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; de Nalda AL; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
    PLoS One; 2020; 15(10):e0241715. PubMed ID: 33113549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2018; 13(4):e0196354. PubMed ID: 29672617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response.
    PLOS ONE Staff
    PLoS One; 2016; 11(7):e0160137. PubMed ID: 27441720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma.
    PLOS ONE Staff
    PLoS One; 2017; 12(11):e0188991. PubMed ID: 29186187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.